Ascendis Pharma A/S Touts €683M Product Revenue, Feb PDUFA Catalyst at JPM Healthcare Conference [Yahoo! Finance]
TEIJIN LTD ADR (TINLY)
NASDAQ:AMEX Investor Relations:
teijin.com/ir
Company Research
Source: Yahoo! Finance
growth, expanding international commercialization, and multiple 2026 clinical and regulatory milestones during a presentation and Q&A at the 44th Annual J.P. Morgan Healthcare Conference. Chief Executive Officer Jan Mikkelsen said Ascendis reported Q4 product revenue of about €240 million and full-year product revenue of about €683 million , describing the company as having achieved “two quarters of a profitable business.” He attributed the revenue base primarily to two commercial products, Yorvipath (TransCon PTH) and Skytrofa , and pointed to an upcoming regulatory decision for TransCon CNP with a PDUFA date at the end of February ? NVIDIA's Next Leg Higher May Have Started at CES 3 Oversold Stocks with Big RSI Rebound Potential Mikkelsen also discussed a longer-term corporate objective, stating Ascendis is now “confident” it can reach more than €5 billion in revenue in 2030 , with the majority expected from the U.S. and a “major contribution” from ex-U.S. markets. On Yorv
Show less
Read more
Impact Snapshot
Event Time:
TINLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TINLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TINLY alerts
High impacting TEIJIN LTD ADR news events
Weekly update
A roundup of the hottest topics
TINLY
News
- Assessing Teijin (TSE:3401) Valuation As Recent Share Price Momentum Follows Loss-Making Results [Yahoo! Finance]Yahoo! Finance
- Automotive Aramid Fiber Market worth $1.30 billion by 2030 - Exclusive Report by MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Teijin (TSE:3401): Assessing Valuation After a Recent Slow but Steady Share Price Rise [Yahoo! Finance]Yahoo! Finance
- A Fresh Look at Teijin (TSE:3401) Valuation After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- Is Teijin's Recent Share Price Drop an Opportunity After Advanced Materials News? [Yahoo! Finance]Yahoo! Finance